| Description | ANKRA2 Human Pre-designed siRNA Set A contains three designed siRNAs for ANKRA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components ANKRA2 siRNA-1: 5 nmol (HPLC) ANKRA2 siRNA-2: 5 nmol (HPLC) ANKRA2 siRNA-3: 5 nmol (HPLC) siRNA Negative ANKRA2 Human Pre-designed siRNA Set A contains three designed siRNAs for ANKRA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components ANKRA2 siRNA-1: 5 nmol (HPLC) ANKRA2 siRNA-2: 5 nmol (HPLC) ANKRA2 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | Inquire | Purity>95% (SDS-PAGE) Endotoxin level<1.0 EU/µgFunctionInhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T-cells | Keratinocyte growth factor (KGF) is a cytokine found by Rubin et al. (1989) from the culture supernatant of embryonic lung fibroblasts, which is a member of the FGF family, namely FGF-7. KGF is an effective epithelial-specific growth factor secreted by mesenchymal cells and distributed in epithelialKeratinocyte growth factor (KGF) is a cytokine found by Rubin et al. (1989) from the culture supernatant of embryonic lung fibroblasts, which is a member of the FGF family, namely FGF-7. KGF is an effective epithelial-specific growth factor secreted by mesenchymal cells and distributed in epithelial cells. Its mitotic activity is mainly manifested in keratinocytes, which can specifically promote the proliferation, migration and differentiation of epithelial cells. It is closely related to organ development, wound repair, tumor genesis and immune reconstruction.Activity definition: The ED50 value is less than 1.0 ng/ml, that is, the corresponding activity unit is greater than or equal to 1 x 10*6 units/mg, as determined by the proliferation method of cultured MCF-7 cells... Read More |